| PERIOD ENDING | 30-Sep-09 | 30-Jun-09 | 31-Mar-09 | 31-Dec-08 | | Total Revenue | 16,819 | 13,055 | 7,654 | 15,646 | | Cost of Revenue | 11,281 | 10,539 | 7,891 | 14,888 | | | Gross Profit | 5,538 | 2,516 | (237) | 758 | | | Operating Expenses | | Research Development | 360 | 355 | 460 | 529 | | Selling General and Administrative | 3,323 | 3,486 | 4,006 | 3,605 | | Non Recurring |
-
|
-
| 507 |
-
| | Others |
-
|
-
|
-
|
-
| | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | 1,855 | (1,325) | (5,210) | (3,376) | | | Income from Continuing Operations | | Total Other Income/Expenses Net | 560 | 355 | (378) | 663 | | Earnings Before Interest And Taxes | 2,532 | (970) | (5,588) | (2,720) | | Interest Expense |
-
|
-
|
-
|
-
| | Income Before Tax | 2,532 | (970) | (5,588) | (2,720) | | Income Tax Expense | 201 | 308 | 4 | (349) | | Minority Interest |
-
|
-
|
-
| (7) | | | | Net Income From Continuing Ops | 2,195 | (1,278) | (5,592) | (2,371) | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | 2,195 | (1,278) | (5,592) | (2,371) | | Preferred Stock And Other Adjustments | (74) | (2) | 76 |
-
| | | Net Income Applicable To Common Shares | $2,121 | ($1,280) | ($5,516) | ($2,371) |
|
0.22% Nasdaq 
Income Statement
